Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
DermatologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Journal of dermatological treatment
- Publicado em
- 2 dez 2025
- Citações
- 6
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
Ruiming Hu, Aihua Wei, Liming Wu, Bin Yang, Ji Li, Linfeng Li, Yi Zhao, Chunjun Yang, Guoqiang Zhang, Yumei Li et al.
Descritores MeSH
- Hair
- Alopecia
- Double-Blind Method
- Humans
- Male
- Middle Aged
- Treatment Outcome
- Administration, Topical
- Young Adult
- Adult
Veja também
Estudos relacionados
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- Caffeine Supplementation and Hair: A Systematic Review
- The Safety and Efficacy of a Novel Saw Palmetto (Serenoa repens) Extract for Promoting Hair Growth in Adults With Self-Perceived Thinning Hair: 180-Day Results
- Efficacy of polyphenolic compounds for hair regeneration: a systematic review and meta-analysis of randomized controlled trials